For most of the 21st century, one theory dominated research efforts to cure Alzheimer’s disease: the Amyloid hypothesis. Beta-amyloid is a protein that builds clumps or tiles, in the brains of people with Alzheimer’s disease and is associated with their cognitive decline.
But in recent years, despite the appearance of several modern drugs focused on these boards, some scientists began to doubt the hypothesis of amyloids. Don Weaver, a professor of chemistry at the University of Toronto in Canada, is one of them.
In this episode Conversation every week Podcast, Weaver tells us about changes in understanding Alzheimer during his career for over 30 years and about what theories appear now in what can cause disease and how to treat it.
Weaver no longer believes that there will be one magic drug that treats Alzheimer’s disease. Instead, he is in favor of approaching a magical shotgun, which will probably require many ways of treating the problem, in which it began much earlier in human life.
Listen to our conversation with Donald Weaver about the weekly podcast.
This episode of The Conversation Weekly was written and produced by Katie Flood with the facilitate of the Mend Mariwana production. It is run by Gemma Ware, which is also an executive producer. Mixing and design of Eloise Stevens sound and motivational music Neeta Sarl.
Listen to the conversation every week via any of the above applications, download it directly through ours RSS Feed Or find out how to listen here else. The transcription of this section is available in Apple podcasts.